Aprea Therapeutics expands IP portfolio for precision oncology programs
Aprea Therapeutics announced an expansion of its intellectual property portfolio for precision oncology programs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
APRE - Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
APRE - Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs